Palisade Bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Palisade Bio Stock Summary

Palisade Bio competes with Zura Bio, Immix Biopharma, Enveric Biosciences, ZyVersa Therapeutics, and Phio Pharmaceuticals. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is headquartered in Carlsbad, California. Palisade Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Palisade Bio Key Financial Ratios

Palisade Bio Key Balance Sheet Accounts

Palisade Bio Key Income Statement Accounts

Palisade Bio Key Cash Accounts

Palisade Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Palisade Bio's current stock value. Our valuation model uses many indicators to compare Palisade Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Palisade Bio competition to find correlations between indicators driving Palisade Bio's intrinsic value. More Info.Palisade Bio is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Palisade Bio's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Palisade Bio's earnings, one of the primary drivers of an investment's value.

Palisade Bio Systematic Risk

Today, most investors in Palisade Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Palisade Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Palisade Bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Palisade Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Palisade Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Palisade Bio based on widely used predictive technical indicators. In general, we focus on analyzing Palisade Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Palisade Bio's daily price indicators and compare them against related drivers.

When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.